Stockreport

I-Mab Reports Third Quarter 2024 Results [Yahoo! Finance]

I-MAB - American Depositary Shares  (IMAB) 
PDF On track to dose first patient in randomized Phase 2 study of uliledlimab in first-line mNSCLC in 1H 2025 Appointed Dr. Sean Fu as permanent CEO effective November 1, [Read more]